Connect with us

Hi, what are you looking for?


This biopharma stock jumped over 250% on Monday: what happened?

why is provention stock up 250% on monday

Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the biopharmaceutical company that focused on autoimmune diseases.

Here’s what we know so far

The French healthcare giant is willing to pay $25 a share for Provention Bio – a little under 300% premium on its previous close.

Sanofi is making the acquisition primarily to add TZIELD to its portfolio – the only treatment known to delay the onset of Stage 3 type 1 diabetes (T1D). In the press release, Olivier Charmeil (Executive Vice President of Sanofi) said:

By coupling Provention’s transformative innovation with Sanofi’s expertise, we aim to bring life-changing benefits to people at risk of developing Stage 3 T1D. We foresee a seamless integration and execution.

The said deal has an equity value of about $2.9 billion.

Sanofi shares ended down today

Provention Bio secured approval for its TZIELD in the United States last year, following which, it signed an agreement with Sanofi to co-promote the monoclonal antibody in the U.S.

The deal announced today is subject to customary closing conditions. According to Ashleigh Palmer – the Chief Executive of Provention Bio Inc:

Sanofi’s global expertise and commitment to immunology makes them an ideal acquiror and positions our innovative therapy to reach more patients as quickly as possible.

Shares of the Paris-headquartered firm ended slightly down on Monday. The stock market news arrives about a month after Sanofi reported about an 18% year-over-year growth in its fourth-quarter revenue.

The post This biopharma stock jumped over 250% on Monday: what happened? appeared first on Invezz.

You May Also Like


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...


Genesis Trading, the cryptocurrency brokerage and lender that halted customer withdrawals in the aftermath of FTX collapse, believes it can sort out its financial...

Editor's Pick

If you haven’t been following the “Twitter Files” saga, the gist of it is that the US federal government routinely pressured pre-Musk Twitter, and...

Editor's Pick

On April 23, 1985, the Coca-Cola Company made one of the biggest mistakes in American business history: it changed the formula for Coca-Cola. Outraged...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023